IBDEI0QH.m

IBDEI0QH ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,11912,1,2,0)

 ;;=2^J3380

 ;;^UTILITY(U,$J,358.3,11912,1,3,0)

 ;;=3^VEDOLIZUMAB/ENTYVIO 1MG

 ;;^UTILITY(U,$J,358.3,11913,0)

 ;;=J7609^^48^580^5^^^^1

 ;;^UTILITY(U,$J,358.3,11913,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11913,1,2,0)

 ;;=2^J7609

 ;;^UTILITY(U,$J,358.3,11913,1,3,0)

 ;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG

 ;;^UTILITY(U,$J,358.3,11914,0)

 ;;=J7610^^48^580^4^^^^1

 ;;^UTILITY(U,$J,358.3,11914,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11914,1,2,0)

 ;;=2^J7610

 ;;^UTILITY(U,$J,358.3,11914,1,3,0)

 ;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG

 ;;^UTILITY(U,$J,358.3,11915,0)

 ;;=J0735^^48^580^27^^^^1

 ;;^UTILITY(U,$J,358.3,11915,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11915,1,2,0)

 ;;=2^J0735

 ;;^UTILITY(U,$J,358.3,11915,1,3,0)

 ;;=3^CLONIDINE HYDROCHLORIDE 1MG

 ;;^UTILITY(U,$J,358.3,11916,0)

 ;;=J1438^^48^580^35^^^^1

 ;;^UTILITY(U,$J,358.3,11916,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11916,1,2,0)

 ;;=2^J1438

 ;;^UTILITY(U,$J,358.3,11916,1,3,0)

 ;;=3^ETANERCEPT 25MG

 ;;^UTILITY(U,$J,358.3,11917,0)

 ;;=J7611^^48^580^6^^^^1

 ;;^UTILITY(U,$J,358.3,11917,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11917,1,2,0)

 ;;=2^J7611

 ;;^UTILITY(U,$J,358.3,11917,1,3,0)

 ;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG

 ;;^UTILITY(U,$J,358.3,11918,0)

 ;;=J7613^^48^580^7^^^^1

 ;;^UTILITY(U,$J,358.3,11918,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11918,1,2,0)

 ;;=2^J7613

 ;;^UTILITY(U,$J,358.3,11918,1,3,0)

 ;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG

 ;;^UTILITY(U,$J,358.3,11919,0)

 ;;=J2680^^48^580^41^^^^1

 ;;^UTILITY(U,$J,358.3,11919,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11919,1,2,0)

 ;;=2^J2680

 ;;^UTILITY(U,$J,358.3,11919,1,3,0)

 ;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG

 ;;^UTILITY(U,$J,358.3,11920,0)

 ;;=J1580^^48^580^47^^^^1

 ;;^UTILITY(U,$J,358.3,11920,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11920,1,2,0)

 ;;=2^J1580

 ;;^UTILITY(U,$J,358.3,11920,1,3,0)

 ;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG

 ;;^UTILITY(U,$J,358.3,11921,0)

 ;;=J2350^^48^580^80^^^^1

 ;;^UTILITY(U,$J,358.3,11921,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11921,1,2,0)

 ;;=2^J2350

 ;;^UTILITY(U,$J,358.3,11921,1,3,0)

 ;;=3^OCRELIZUMAB 1MG

 ;;^UTILITY(U,$J,358.3,11922,0)

 ;;=J3590^^48^580^105^^^^1

 ;;^UTILITY(U,$J,358.3,11922,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11922,1,2,0)

 ;;=2^J3590

 ;;^UTILITY(U,$J,358.3,11922,1,3,0)

 ;;=3^UNCLASSIFIED BIOLOGICS

 ;;^UTILITY(U,$J,358.3,11923,0)

 ;;=J3490^^48^580^106^^^^1

 ;;^UTILITY(U,$J,358.3,11923,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11923,1,2,0)

 ;;=2^J3490

 ;;^UTILITY(U,$J,358.3,11923,1,3,0)

 ;;=3^UNCLASSIFIED DRUG

 ;;^UTILITY(U,$J,358.3,11924,0)

 ;;=J0135^^48^580^3^^^^1

 ;;^UTILITY(U,$J,358.3,11924,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11924,1,2,0)

 ;;=2^J0135

 ;;^UTILITY(U,$J,358.3,11924,1,3,0)

 ;;=3^ADALIMUMAB 20MG

 ;;^UTILITY(U,$J,358.3,11925,0)

 ;;=J1569^^48^580^45^^^^1

 ;;^UTILITY(U,$J,358.3,11925,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11925,1,2,0)

 ;;=2^J1569

 ;;^UTILITY(U,$J,358.3,11925,1,3,0)

 ;;=3^GAMMAGARD LIQUID 500MG

 ;;^UTILITY(U,$J,358.3,11926,0)

 ;;=J1566^^48^580^51^^^^1

 ;;^UTILITY(U,$J,358.3,11926,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,11926,1,2,0)

 ;;=2^J1566

 ;;^UTILITY(U,$J,358.3,11926,1,3,0)

 ;;=3^IMMUNE GLOBULIN 500MG

 ;;^UTILITY(U,$J,358.3,11927,0)

 ;;=J2182^^48^580^69^^^^1

 ;;^UTILITY(U,$J,358.3,11927,1,0)

 ;;=^358.31IA^3^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI0QH   3769     printed  Feb 18, 2025@23:20:09                                                                                                                                                                                                    Page 2

IBDEI0QH  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,11912,1,2,0)

 +2       ;;=2^J3380

 +3       ;;^UTILITY(U,$J,358.3,11912,1,3,0)

 +4       ;;=3^VEDOLIZUMAB/ENTYVIO 1MG

 +5       ;;^UTILITY(U,$J,358.3,11913,0)

 +6       ;;=J7609^^48^580^5^^^^1

 +7       ;;^UTILITY(U,$J,358.3,11913,1,0)

 +8       ;;=^358.31IA^3^2

 +9       ;;^UTILITY(U,$J,358.3,11913,1,2,0)

 +10      ;;=2^J7609

 +11      ;;^UTILITY(U,$J,358.3,11913,1,3,0)

 +12      ;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG

 +13      ;;^UTILITY(U,$J,358.3,11914,0)

 +14      ;;=J7610^^48^580^4^^^^1

 +15      ;;^UTILITY(U,$J,358.3,11914,1,0)

 +16      ;;=^358.31IA^3^2

 +17      ;;^UTILITY(U,$J,358.3,11914,1,2,0)

 +18      ;;=2^J7610

 +19      ;;^UTILITY(U,$J,358.3,11914,1,3,0)

 +20      ;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG

 +21      ;;^UTILITY(U,$J,358.3,11915,0)

 +22      ;;=J0735^^48^580^27^^^^1

 +23      ;;^UTILITY(U,$J,358.3,11915,1,0)

 +24      ;;=^358.31IA^3^2

 +25      ;;^UTILITY(U,$J,358.3,11915,1,2,0)

 +26      ;;=2^J0735

 +27      ;;^UTILITY(U,$J,358.3,11915,1,3,0)

 +28      ;;=3^CLONIDINE HYDROCHLORIDE 1MG

 +29      ;;^UTILITY(U,$J,358.3,11916,0)

 +30      ;;=J1438^^48^580^35^^^^1

 +31      ;;^UTILITY(U,$J,358.3,11916,1,0)

 +32      ;;=^358.31IA^3^2

 +33      ;;^UTILITY(U,$J,358.3,11916,1,2,0)

 +34      ;;=2^J1438

 +35      ;;^UTILITY(U,$J,358.3,11916,1,3,0)

 +36      ;;=3^ETANERCEPT 25MG

 +37      ;;^UTILITY(U,$J,358.3,11917,0)

 +38      ;;=J7611^^48^580^6^^^^1

 +39      ;;^UTILITY(U,$J,358.3,11917,1,0)

 +40      ;;=^358.31IA^3^2

 +41      ;;^UTILITY(U,$J,358.3,11917,1,2,0)

 +42      ;;=2^J7611

 +43      ;;^UTILITY(U,$J,358.3,11917,1,3,0)

 +44      ;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG

 +45      ;;^UTILITY(U,$J,358.3,11918,0)

 +46      ;;=J7613^^48^580^7^^^^1

 +47      ;;^UTILITY(U,$J,358.3,11918,1,0)

 +48      ;;=^358.31IA^3^2

 +49      ;;^UTILITY(U,$J,358.3,11918,1,2,0)

 +50      ;;=2^J7613

 +51      ;;^UTILITY(U,$J,358.3,11918,1,3,0)

 +52      ;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG

 +53      ;;^UTILITY(U,$J,358.3,11919,0)

 +54      ;;=J2680^^48^580^41^^^^1

 +55      ;;^UTILITY(U,$J,358.3,11919,1,0)

 +56      ;;=^358.31IA^3^2

 +57      ;;^UTILITY(U,$J,358.3,11919,1,2,0)

 +58      ;;=2^J2680

 +59      ;;^UTILITY(U,$J,358.3,11919,1,3,0)

 +60      ;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG

 +61      ;;^UTILITY(U,$J,358.3,11920,0)

 +62      ;;=J1580^^48^580^47^^^^1

 +63      ;;^UTILITY(U,$J,358.3,11920,1,0)

 +64      ;;=^358.31IA^3^2

 +65      ;;^UTILITY(U,$J,358.3,11920,1,2,0)

 +66      ;;=2^J1580

 +67      ;;^UTILITY(U,$J,358.3,11920,1,3,0)

 +68      ;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG

 +69      ;;^UTILITY(U,$J,358.3,11921,0)

 +70      ;;=J2350^^48^580^80^^^^1

 +71      ;;^UTILITY(U,$J,358.3,11921,1,0)

 +72      ;;=^358.31IA^3^2

 +73      ;;^UTILITY(U,$J,358.3,11921,1,2,0)

 +74      ;;=2^J2350

 +75      ;;^UTILITY(U,$J,358.3,11921,1,3,0)

 +76      ;;=3^OCRELIZUMAB 1MG

 +77      ;;^UTILITY(U,$J,358.3,11922,0)

 +78      ;;=J3590^^48^580^105^^^^1

 +79      ;;^UTILITY(U,$J,358.3,11922,1,0)

 +80      ;;=^358.31IA^3^2

 +81      ;;^UTILITY(U,$J,358.3,11922,1,2,0)

 +82      ;;=2^J3590

 +83      ;;^UTILITY(U,$J,358.3,11922,1,3,0)

 +84      ;;=3^UNCLASSIFIED BIOLOGICS

 +85      ;;^UTILITY(U,$J,358.3,11923,0)

 +86      ;;=J3490^^48^580^106^^^^1

 +87      ;;^UTILITY(U,$J,358.3,11923,1,0)

 +88      ;;=^358.31IA^3^2

 +89      ;;^UTILITY(U,$J,358.3,11923,1,2,0)

 +90      ;;=2^J3490

 +91      ;;^UTILITY(U,$J,358.3,11923,1,3,0)

 +92      ;;=3^UNCLASSIFIED DRUG

 +93      ;;^UTILITY(U,$J,358.3,11924,0)

 +94      ;;=J0135^^48^580^3^^^^1

 +95      ;;^UTILITY(U,$J,358.3,11924,1,0)

 +96      ;;=^358.31IA^3^2

 +97      ;;^UTILITY(U,$J,358.3,11924,1,2,0)

 +98      ;;=2^J0135

 +99      ;;^UTILITY(U,$J,358.3,11924,1,3,0)

 +100     ;;=3^ADALIMUMAB 20MG

 +101     ;;^UTILITY(U,$J,358.3,11925,0)

 +102     ;;=J1569^^48^580^45^^^^1

 +103     ;;^UTILITY(U,$J,358.3,11925,1,0)

 +104     ;;=^358.31IA^3^2

 +105     ;;^UTILITY(U,$J,358.3,11925,1,2,0)

 +106     ;;=2^J1569

 +107     ;;^UTILITY(U,$J,358.3,11925,1,3,0)

 +108     ;;=3^GAMMAGARD LIQUID 500MG

 +109     ;;^UTILITY(U,$J,358.3,11926,0)

 +110     ;;=J1566^^48^580^51^^^^1

 +111     ;;^UTILITY(U,$J,358.3,11926,1,0)

 +112     ;;=^358.31IA^3^2

 +113     ;;^UTILITY(U,$J,358.3,11926,1,2,0)

 +114     ;;=2^J1566

 +115     ;;^UTILITY(U,$J,358.3,11926,1,3,0)

 +116     ;;=3^IMMUNE GLOBULIN 500MG

 +117     ;;^UTILITY(U,$J,358.3,11927,0)

 +118     ;;=J2182^^48^580^69^^^^1

 +119     ;;^UTILITY(U,$J,358.3,11927,1,0)

 +120     ;;=^358.31IA^3^2